Deep Dive Into Glaukos Stock: Analyst Perspectives (12 Ratings)
Glaukos (NYSE:GKOS) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. ...
Source: businessinsider.com
Michael Sarcone News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Michael Sarcone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Michael Sarcone Today - Breaking & Trending Today
AxoGen, Inc. (NASDAQ:AXGN) Q1 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the AxoGen, Inc. 2024 First Quarter Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
Source: insidermonkey.com
Glaukos : Q1 2024 Earnings Transcript - MarketScreener
Corrected Transcript 01-May-2024 Glaukos Corp. Q1 2024 Earnings Call ...
Source: marketscreener.com
Teleflex Incorporated (NYSE:TFX) Q4 2023 Earnings Call Transcript
Teleflex Incorporated beats earnings expectations. Reported EPS is $3.38, expectations were $3.26.
Source: insidermonkey.com
Glaukos Stock Surges After FDA iDose Approval - Orange County Business Journal
Glaukos, founded in 1998, pioneered the now well-established microinvasive glaucoma surgery (MIGS) marketplace. Its best-known product is the iStent, which is among the smallest medical devices ever made.
Source: ocbj.com